GL1X · GenesisL1 explorer

MolNFT v1 · #167516 · protein

JAK2 JH1 in complex with BL2-096

6VNC · Tyrosine-protein kinase JAK2: “JAK2 JH1 in complex with BL2-096”. X-ray diffraction, 1 ligand (R6V), 5 pockets (best druggability 0.77). MolNFT v1 #167516 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6VNC
Type
protein
Length
586 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.10.2
UniProt
O60674
Ligands
R6V
Pockets
5 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BTyrosine-protein kinase JAK2 (EC 2.7.10.2)protein28941% helix, 20% strandO60674
ATyrosine-protein kinase JAK2 (EC 2.7.10.2)protein29742% helix, 21% strandO60674

Ligands and binding sites

  • R6V · (3R)-3-cyclopentyl-3-[4-(2-{[4-(piperidin-4-yl) phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile · ligand · 2 copies · chains B, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15760.770.8463empty
24110.710.8250R6V
34190.700.8151R6V
4780.410.7915empty
5700.340.7617empty

Interfaces

1 interface between chains.

  • B–A · 469 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified, 1 covalent (phosphorylation, covalent ligand).

Compared structures

  • 6VNC · JAK2 JH1 in complex with BL2-096 · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.